Publication: Surveillance of artemisinin resistance in Plasmodium falciparum in India using the kelch13 molecular marker
Issued Date
2015-05-01
Resource Type
ISSN
10986596
00664804
00664804
Other identifier(s)
2-s2.0-84931292116
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antimicrobial Agents and Chemotherapy. Vol.59, No.5 (2015), 2548-2553
Suggested Citation
Neelima Mishra, Surendra Kumar Prajapati, Kamlesh Kaitholia, Ram Suresh Bharti, Bina Srivastava, Sobhan Phookan, Anupkumar R. Anvikar, Vas Dev, Gagan Singh Sonal, Akshay Chandra Dhariwal, Nicholas J. White, Neena Valecha Surveillance of artemisinin resistance in Plasmodium falciparum in India using the kelch13 molecular marker. Antimicrobial Agents and Chemotherapy. Vol.59, No.5 (2015), 2548-2553. doi:10.1128/AAC.04632-14 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/36455
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Surveillance of artemisinin resistance in Plasmodium falciparum in India using the kelch13 molecular marker
Abstract
Copyright © 2015, American Society for Microbiology. All Rights Reserved. Malaria treatment in Southeast Asia is threatened with the emergence of artemisinin-resistant Plasmodium falciparum. Genome association studies have strongly linked a locus on P. falciparum chromosome 13 to artemisinin resistance, and recently, mutations in the kelch13 propeller region (Pfk-13) were strongly linked to resistance. To date, this information has not been shown in Indian samples. Pfk-13 mutations were assessed in samples from efficacy studies of artemisinin combination treatments in India. Samples were PCR amplified and sequenced from codon 427 to 727. Out of 384 samples, nonsynonymous mutations in the propeller region were found in four patients from the northeastern states, but their presence did not correlate with ACT treatment failures. This is the first report of Pfk-13 point mutations from India. Further phenotyping and genotyping studies are required to assess the status of artemisinin resistance in this region.
